COMPANY PROFILE -Emergent BioSolutions Inc.
Business Sector :Biotechnology
Operating Geography :United States, North America, Global
About Emergent BioSolutions Inc. :
Emergent BioSolutions Inc., headquartered in Gaithersburg, Maryland, is an American multinational specialty biopharmaceutical company. It creates vaccines and antibody therapeutics to treat infectious diseases and opioid overdoses, as well as biodefense medical devices. Faud El-Hibri created Emergent BioSolutions on September 5, 1998, under the name BioPort, and renamed it Emergent BioSolutions in 2004.The company has four main units: vaccines, which manufactures specialty vaccines for public health threats; devices, which include nasal sprays, skin lotions, and injections; therapeutics, which involves antibiotic treatments; and contract development and production, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the US government. The majority of revenue comes from vaccination, device, and medicinal product purchases by the US government. On June 11, 2021 the company announced that two batches of COVID-19 vaccine manufactured at its Baltimore Bayview facility had been determined to be suitable for use by the US Food and Drug Administration (FDA) and had been authorised as part of Johnson & Johnson's Emergency Use Authorization programme (EUA).
Emergent BioSolutions's unique selling point or USP lies in its wide product and service portfolio, which allows it to remain confident in executing its plan, meeting its commitments to partners and consumers, and producing value for its shareholders. Emergent BioSolutions's mission statement reads, "Emergent's mission to protect and enhance life applies not only to the products and services that we deliver, but also to how we serve the communities in which we live and work. Our eGive program enables every employee to bring their skills, their passion and their energy to building healthier and safer communities".
Emergent BioSolutions Inc. Revenue :
US$ 1,555 million - FY ending 31st December 2020 (y-o-y growth 40.6%)
US$ 1,106 million - FY ending 31st December 2019
Competitive Analysis of Emergent BioSolutions Inc.
The SWOT analysis for Emergent BioSolutions Inc. is presented below in a matrix followed by the detailed analysis report:
Strengths | Weaknesses |
1. Largest supplier of BioThrax, the only FDA approved anthrax vaccine
2. Diversified portfolio of products + pipeline plus CDMO services
3. Strong public private partnerships
4. Readiness to battle the biochemical threats
5. Established manufacturing expertise through own and contractual locations
| 1. Ongoing investigations regarding government vaccine contracts
2. Substantial portion of revenues dependent on USG procurement
3. History of manufacturing failures
4 Top management not adhering to stock market regulations
5. Poorly trained employees, incapable of expanding production
|
Opportunities | Threats |
1. Increasing public health threats to drive growth
2. Worsened opioid crisis, boosts demand for NARCAN
3. Product candidates to cure critical Covid-19 patients
| 1. Poor image will cause loss of existing contracts
2. Disruption of travel related vaccines due to Covid-19
3. Delayed product launches due to cancellations of clinical trials in Covid
|
Emergent BioSolutions Inc. SWOT and PESTLE Analysis PDF Report is a custom report and will be delivered to your email inbox within 2 business days from purchase.
Detailed SWOT Analysis of Emergent BioSolutions Inc.
Strength
1. Largest supplier of BioThrax, the only FDA approved anthrax vaccine:
BioThrax is the only anthrax vaccine approved under FDA animal rule, in thr USA. It was developed by Emergent BioSolutions in partnership with BARDA and NIAID. The company’s strategy to innovate at every stage has helped it achieve this milestone. It has exclusive rights to use BioThrax for pre-exposure prophylaxis of anthrax, till 2022. The vaccine has also been approved for use in post-exposure prophylaxis of anthrax. In December 2016, the company signed a contract of five years with the Centers for Disease Control and Prevention. The company will provide 29.4 million doses to the agency. These will be part of Strategic National Stockpile. The company is thus contributing towards national security from biological weapons. A monopoly into this segment has given Emergent BioSolutions the ability to comfortably venture into other vaccines.
The remaining section under "Strength" is available only in the 'Complete Report' on purchase.
Weakness
1. Ongoing investigations regarding government vaccine contracts:
Emergent BioSolutions shot into limelight for its mixing up of ingredients during production of two vaccines. This mistake has spoiled 15 million of Johnson & Johnson vaccine doses at Baltimore plant. Also 24 million doses that were expected next month, were not delivered due to this issue. This has not only been the reason for investigation of senior executives but also the Trump administration which approved government funds to produce pandemic vaccines. It has been found that the company’s deep relations with government might have helped it to get these contracts. This is being suspected because the company was clearly involved in previous manufacturing failures. Also, the inspecting agencies found lack of cleanliness and cracked vials at the production facility. This puled down the value of the company drastically. This poor image in front of government agencies is hindering Emergent BioSolutions from helping in the fight against Covid-19.
The remaining section under "Weakness" is available only in the 'Complete Report' on purchase.
Opportunity
This section is available only in the 'Complete Report' on purchase.
Threat
This section is available only in the 'Complete Report' on purchase.
The PESTLE analysis for Emergent BioSolutions Inc. is presented below in a table followed by the detailed analysis report.
Political | Economical |
1. Government funding diverted from flagship products due to Covid
2. Joe Biden’s strengthened implementation of Affordable Care Act affects pricing
| 1. Discontinuation of LIBOR complicates financing
2. High flow of investments into health and biotechnology
|
Social | Technological |
1. Vaccine makers are venerated as they give hope | 1. Mixed vaccine can fight multiple strains of a virus
2. mRNA technology is the future of biopharmaceuticals
|
Legal | Environmental |
1. Pandemic Act (PAHPA) of 2019 authorizes better funding for product development
2. FDA approvals take long durations and substantial financial resources
| 1. Experimental use of animals must follow stringent norms |
Emergent BioSolutions Inc. SWOT and PESTLE Analysis PDF Report is a custom report and will be delivered to your email inbox within 2 business days from purchase.
Detailed Pestle Analysis of Emergent BioSolutions Inc.
Political
This section is available only in the 'Complete Report' on purchase.
Economic
This section is available only in the 'Complete Report' on purchase.
Social
This section is available only in the 'Complete Report' on purchase.
Technological
1. Mixed vaccine can fight multiple strains of a virus:
As multiple Covid-19 waves are causing devastations across the globe, it is being found that there are numerous strains of the virus. These strains will continue to increase due to mutations. Towards the end of 2021 fiscal, a new deadly Omicron variant has surfaced. The vaccine developers have introduced the thought of regular vaccine shots to safeguard against this situation. The newer vaccine shots need to be effective against a cumulative of all the strains that are affecting populations across the world. These mixed vaccines can be developed by combining various vaccines made with the same viral vector but expressing different proteins or by having a mixture of multiple proteins on a single vector. Every strain of virus will have a different protein. For this the vaccine manufacturers must be dynamic in adopting to new production sequence. Emergent BioSolutions must be ready for further rounds of Covid-19 vaccines as it is the contract manufacture for Johnson & Johnson and AstraZeneca.
The remaining section under "Technological" is available only in the 'Complete Report' on purchase.
Legal
This section is available only in the 'Complete Report' on purchase.
Environmental
This section is available only in the 'Complete Report' on purchase.
Major Competitors :
- Altimmune Inc.
- GC Pharma
- Blue Willow Biologics
- Greffex
- Teva Pharmaceuticals Industries Ltd.
- Amphastar Pharmaceuticals Inc.
- Kaleo’s EVZIO
- Teleflex Medical Inc
- SIGA Technologies Inc.
- Elusys Therapeutics Inc
Major Brands :
- Emergent BioSolutions
- PaxVax
- Cangene
- Cangene bioPharma
- ADAPT Pharma Inc.
- Emergent BioSolutions Canada Inc.
- Emergent Travel Health Inc.
Emergent BioSolutions Inc. SWOT and PESTLE Analysis PDF Report is a custom report and will be delivered to your email inbox within 2 business days from purchase.
TABLE OF CONTENTS
DELIVERY AND FORMAT
WHY CHOOSE US?
You may also be interested in other analyses of Emergent BioSolutions Inc.:
-
Emergent BioSolutions Inc. Porter's Five Forces Analysis |
|
-
Emergent BioSolutions Inc. VRIO Analysis |
|
-
Emergent BioSolutions Inc. Value Chain Analysis |
|
-
Emergent BioSolutions Inc. Covid-19 Impact Analysis |
|
-
Emergent BioSolutions Inc. BCG Analysis |
|
-
Emergent BioSolutions Inc. Segmentation, Targeting and Positioning (STP) Analysis |
|
-
Emergent BioSolutions Inc. Ansoff Matrix Analysis |
|
Request for Quotation
Emergent BioSolutions Inc.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Company Overview Report
This report is shared in order to give you an idea of what the complete Company Overview Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Emergent BioSolutions Inc.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Competitor Analysis Report
This report is shared in order to give you an idea of what the complete Competitor Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Emergent BioSolutions Inc.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Porter's Five Forces Analysis Report
This report is shared in order to give you an idea of what the complete Porter's Five Forces Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Emergent BioSolutions Inc.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
VRIO Analysis Report
This report is shared in order to give you an idea of what the complete VRIO Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Emergent BioSolutions Inc.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Value Chain Analysis Report
This report is shared in order to give you an idea of what the complete Value Chain Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Emergent BioSolutions Inc.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Regulatory Outlook Report
This report is shared in order to give you an idea of what the complete Regulatory Outlook Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Emergent BioSolutions Inc.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Risk Analysis Report
This report is shared in order to give you an idea of what the complete Risk Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Emergent BioSolutions Inc.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Key Performance Indicators (KPI's) Report
This report is shared in order to give you an idea of what the complete Key Performance Indicators (KPI's) Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Emergent BioSolutions Inc.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Environmental, Social, and Governance (ESG) Analysis Report
This report is shared in order to give you an idea of what the complete Environmental, Social, and Governance (ESG) Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Emergent BioSolutions Inc.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
M&A Analysis Report
This report is shared in order to give you an idea of what the complete M&A Report and Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Emergent BioSolutions Inc.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Subsidiaries, Partnerships and Collaborations Report
This report is shared in order to give you an idea of what the complete Subsidiaries, Partnerships and Collaborations Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Emergent BioSolutions Inc.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Stakeholder Analysis Report
This report is shared in order to give you an idea of what the complete Stakeholder Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Emergent BioSolutions Inc.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Technology Landscape and Outlook Report
This report is shared in order to give you an idea of what the complete Technology Landscape and Outlook Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Emergent BioSolutions Inc.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Covid-19 Impact Analysis Report
This report is shared in order to give you an idea of what the complete Covid-19 Impact Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Emergent BioSolutions Inc.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Key News and Events Report
This report is shared in order to give you an idea of what the complete Key News and Events Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Emergent BioSolutions Inc.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
BCG Analysis Report
This report is shared in order to give you an idea of what the complete BCG Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Emergent BioSolutions Inc.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Digital Marketing and Social Media Strategy Analysis Report
This report is shared in order to give you an idea of what the complete Digital Marketing and Social Media Strategy Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Emergent BioSolutions Inc.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Segmentation, Targeting and Positioning (STP) Analysis Report
This report is shared in order to give you an idea of what the complete Segmentation, Targeting and Positioning (STP) Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Emergent BioSolutions Inc.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Ansoff Matrix Analysis Report
This report is shared in order to give you an idea of what the complete Ansoff Matrix Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Check Out Analysis of Other Relevant Companies
References used in Emergent BioSolutions Inc. SWOT & PESTLE Analysis Report
1. At Emergent, we take a whole-company
approach to Innovation. - https://www.emergentbiosolutions.com/our-innovation
2. Manufacturing Expertise: Protecting and Enhancing Life in Every Single Dose - https://www.emergentbiosolutions.com/manufacturing-expertise#capabilities
3. ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 -- https://investors.emergentbiosolutions.com/static-files/139a4191-2e9e-4db8-a6bc-0d3e9340adf9
4. Emergent BioSolutions CEO, founder head for the Hill as Congress probes production contracts, errors - https://www.fiercepharma.com/manufacturing/top-emergent-execs-head-for-hill-as-congress-investigates-company-s-covid-19
5. Warren Calls on SEC to Investigate Potential Insider Trading by CEO of Emergent BioSolutions, Company That Ruined 15 Million Doses of Johnson & Johnson COVID Vaccine - https://yubanet.com/usa/warren-calls-on-sec-to-investigate-potential-insider-trading-by-ceo-of-emergent-biosolutions-company-that-ruined-15-million-doses-of-johnson-johnson-covid-vaccine/
The detailed complete set of references are available on request in the 'Complete report' on purchase.
How to Reference This Page?
You can use the following in your reference section in order to give credit to the source. For different referencing styles and detailed guidelines, please click here.
Emergent BioSolutions Inc. SWOT and PESTLE Analysis - SWOT & PESTLE.COM
SWOT & PESTLE.com (2025). Emergent BioSolutions Inc. SWOT and PESTLE Analysis - SWOT & PESTLE.com. [online] Available at: https://www.swotandpestle.com/emergent-biosolutions/ [Accessed 28 Mar, 2025].
In-text: (SWOT & PESTLE.com, 2025)
Copyrights and Disclaimer
Emergent BioSolutions Inc. SWOT and PESTLE analysis has been conducted by Mohit Harishchandra Deshmukh and reviewed by senior analysts from Barakaat Consulting.
Copyright of Emergent BioSolutions Inc. SWOT and PESTLE Analysis is the property of Barakaat Consulting. Please refer to the Terms and Conditions and Disclaimer for usage guidelines.